Triose Phosphate Isomerase Structure-Based Virtual Screening and In Vitro Biological Activity of Natural Products as <i>Leishmania mexicana</i> Inhibitors
Cutaneous leishmaniasis (CL) is a public health problem affecting more than 98 countries worldwide. No vaccine is available to prevent the disease, and available medical treatments cause serious side effects. Additionally, treatment failure and parasite resistance have made the development of new dr...
Main Authors: | Luis D. González-Morales, Adriana Moreno-Rodríguez, Lenci K. Vázquez-Jiménez, Timoteo Delgado-Maldonado, Alfredo Juárez-Saldivar, Eyra Ortiz-Pérez, Alma D. Paz-Gonzalez, Edgar E. Lara-Ramírez, Lilian Yépez-Mulia, Patricia Meza, Gildardo Rivera |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-07-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/15/8/2046 |
Similar Items
-
Virtual Screening of Benzimidazole Derivatives as Potential Triose Phosphate Isomerase Inhibitors with Biological Activity against <i>Leishmania mexicana</i>
by: Lenci K. Vázquez-Jiménez, et al.
Published: (2023-03-01) -
Purification and Partial Characterization of Trypanosoma cruzi Triosephosphate Isomerase
by: Bourguignon SC, et al.
Published: (1998-01-01) -
Identification of fibrillogenic regions in human triosephosphate isomerase
by: Edson N. Carcamo-Noriega, et al.
Published: (2016-02-01) -
C-Terminal Lysine Residue of Pneumococcal Triosephosphate Isomerase Contributes to Its Binding to Host Plasminogen
by: Satoru Hirayama, et al.
Published: (2023-05-01) -
Esters of quinoxaline-7-carboxylate-1,4-di-N-oxide as Trichomonas vaginalis triosephosphate isomerase inhibitors
by: Palos Isidro, et al.
Published: (2021-09-01)